The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).
Large Cap Gainers
MT (11.2 +5.86%): Sector strength in metals (VALE, FCX, NUE also higher).
DG (75.26 +3.36%): Beat Q1 consensus EPS estimates by $0.03, reported revs in-line; reaffirmed FY16 guidance.
AER (50.13 +3.92%): Launched a secondary offering of 50 mln shares on behalf of American Intl (AIG), said it would repurchase up to $750 mln of the offering.
Large Cap Losers
CTRP (77.36 -5.23%): Under pressure after Qunar (QUNR) says it rejected an unsolicited takeover proposal from Ctrip; also downgraded at Stifel.
DAL (43.42 -2.1%): Announced that May PRASM fell 5.5% y/y.
INTC (33.34 -1.68%): Downgraded to Market Perform from Outperform at BMO Capital.
Mid Cap Gainers
JUNO (60.15 +13.34%): Outperforming after AstraZeneca (AZN) said it may be interested in names in the immuno-oncology space; Juno also announced it would acquire X-BODY, a privately-held biotech.
PVH (113.24 +8.18%): Beat Q1 consensus EPS estimates by $0.12, reported revs in-line; guided Q2 EPS in-line, revs below consensus; raised FY16 EPS; reaffirmed sales ex-FX; announced $500 mln buyback.
ZION (30.47 +6.54%): Announced a corporate restructuring in conjunction with several expense and revenue initiatives; Upgraded Guggenheim, Evercore ISI, Credit Agricole, others.
Mid Cap Losers
PBYI (149.01 -12.33%): Continued weakness following the release of ExteNET trial data for neratinib.
IRM (34.86 -5.35%): Downgraded to Underperform from Hold at Jefferies.
CG (29.47 -4.84%): Announced an offering of 7 mln shares of common stock.